Miruvor
Sign up
The short answer

What studies of cardio / aerobic exercise found

59papers on cardio / aerobic exercise
205people in 7 studies testing cardio / aerobic exercise alone
4randomised trials, the strongest kind of study

At a glance, by condition

Long COVID: C Mixed results

Based on the strongest evidence, randomised trials and studies with no comparison group and the randomised trial (very low certainty): 11 of 18 findings are C.

12 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: Studies of cardio / aerobic exercise for long COVID disagree, so it’s not clear whether it helps. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 59 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. Cardio / aerobic exercise · Long COVID is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

Long COVID

Symptoms

Breathlessness4 studies · 94 people took part in cardio / aerobic exercise Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (123 in all); the studies disagree; randomised trials found mixed results.

Randomised trials2 studies · 123 people with results

Studies disagree about breathlessness.

Studies disagree about whether Cardio / aerobic exercise helps breathlessness. Mixed results · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (123 in all)
  • The studies disagree

Studies with no comparison group2 studies · 34 people with results

Studies disagree about breathlessness.

Studies disagree about whether Cardio / aerobic exercise helps breathlessness. Mixed results · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (34 in all)
  • The studies disagree
See the 4 studies
  1. Continuous versus low-intensity interval aerobic exercise in pulmonary rehabilitation after COVID-19. (2025)

    People in the study
    76 randomised · 63 analysed
    Dose
    40% of the peak workload, 15 sessions; 5-min warm up, 20-min exercise, 5-min cool-down period; three or five times a week
    Outcome
    mMRC Modified Medical Research Council dyspnea scale
    Effect
    worse
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Effectiveness of endurance training rehabilitation after hospitalisation in intensive care for COVID-19-related acute respiratory distress syndrome on dyspnoea (RECOVER): a randomised controlled, open-label multicentre trial (2022) preprint

    People in the study
    60 randomised
    Dose
    two one-hour sessions per week, for 10 weeks
    Outcome
    MDP total score Multidimensional Dyspnea Profile
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  3. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    shortness of breath 7-Day Symptom Diary
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  4. Effects of Six Weeks of Supervised Telerehabilitation on Pulmonary Function, Functional Capacity, and Dyspnoea among individuals with Long COVID (2023) preprint

    People in the study
    20 in the study
    Dose
    40 minutes, three synchronous sessions per week
    Outcome
    FVC pulmonary function test (PFT)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Autonomic symptoms2 studies · 47 people took part in cardio / aerobic exercise Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from randomised trials: some concerns about bias (RoB 2); few people (105 in all); the studies disagree; randomised trials found mixed results.

Randomised trials2 studies · 105 people with results

Studies disagree about autonomic symptoms.

Studies disagree about whether Cardio / aerobic exercise helps autonomic symptoms. Mixed results · very low certainty C

  • Some concerns about bias (RoB 2)
  • Few people (105 in all)
  • The studies disagree
See the 2 studies
  1. Exercise rehabilitation in post COVID-19 patients: a randomized controlled trial of different training modalities. (2025)

    People in the study
    66 randomised · 42 analysed
    Dose
    3x/week; 30min/session first two weeks, then two sessions at VT1 and one interval session, 3x/week on non-consecutive days
    Outcome
    RMSSD (ms) heart rate variability (HRV) assessment
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
  2. Continuous versus low-intensity interval aerobic exercise in pulmonary rehabilitation after COVID-19. (2025)

    People in the study
    76 randomised · 63 analysed
    Dose
    40% of the peak workload, 15 sessions; 5-min warm up, 20-min exercise, 5-min cool-down period; three or five times a week
    Outcome
    Resting HR (bpm)
    Effect
    worse
    Risk of bias
    RoB 2: Some concerns
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
Pain2 studies · 15 people took part in cardio / aerobic exercise Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (15 in all); not all results were tested against chance; the studies disagree.

Studies with no comparison group2 studies · 15 people with results

Studies disagree about pain.

Studies disagree about whether Cardio / aerobic exercise helps pain. Mixed results · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (15 in all)
  • Not all results were tested against chance
  • The studies disagree
See the 2 studies
  1. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    pain
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  2. Corona With Lyme: A Long COVID Case Study. (2023)

    People in the study
    1 in the study
    Dose
    with extensive rest periods before, during, and after exercise
    Outcome
    severity and frequency of associated myalgias, headaches, and scalp allodynia
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Depression1 study · 14 people took part in cardio / aerobic exercise Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (14 in all).

Studies with no comparison group21 in the study · 14 with outcome data · 10 weeks · 10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions

Depression improved.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on depression in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (14 in all)
See the 1 study
  1. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    depression scores (PHQ-9) Patient Health Depression Questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Low mood or anxiety2 studies · 47 people took part in cardio / aerobic exercise Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 63 people found no clear difference; a small benefit can't be ruled out.

The randomised trial76 randomised · 63 analysed · 15 sessions · 40% of the peak workload, 15 sessions; 5-min warm up, 20-min exercise, 5-min cool-down period; three or five times a week

No clear difference in low mood or anxiety.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on low mood or anxiety in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 63 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group21 in the study · 14 with outcome data · 10 weeks · 10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions

Low mood or anxiety improved.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on low mood or anxiety in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (14 in all)
  • Not all results were tested against chance
  • Only people who finished were analysed
See the 2 studies
  1. Continuous versus low-intensity interval aerobic exercise in pulmonary rehabilitation after COVID-19. (2025)

    People in the study
    76 randomised · 63 analysed
    Dose
    40% of the peak workload, 15 sessions; 5-min warm up, 20-min exercise, 5-min cool-down period; three or five times a week
    Outcome
    HADS anxiety Hospital Anxiety and Depression Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    emotional well-being Short Form Health Survey (SF-36)
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Cognition (brain fog)2 studies · 28 people took part in cardio / aerobic exercise Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 42 people found no clear difference; a small benefit can't be ruled out.

The randomised trial66 randomised · 42 analysed · 12 weeks · 3x/week; 30min/session first two weeks, then two sessions at VT1 and one interval session, 3x/week on non-consecutive days

No clear difference in cognition (brain fog).

The evidence is very uncertain about the effect of Cardio / aerobic exercise on cognition (brain fog) in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 42 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group21 in the study · 14 with outcome data · 10 weeks · 10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions

Cognition (brain fog) improved.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on cognition (brain fog) in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (14 in all)
See the 2 studies
  1. Exercise rehabilitation in post COVID-19 patients: a randomized controlled trial of different training modalities. (2025)

    People in the study
    66 randomised · 42 analysed
    Dose
    3x/week; 30min/session first two weeks, then two sessions at VT1 and one interval session, 3x/week on non-consecutive days
    Outcome
    Concentration performance Cognitrone
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    brain fog 7-Day Symptom Diary
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Fatigue2 studies · 28 people took part in cardio / aerobic exercise Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 42 people found no clear difference; a small benefit can't be ruled out; effect size 0.09 (very small).

The randomised trial66 randomised · 42 analysed · 12 weeks · 3x/week; 30min/session first two weeks, then two sessions at VT1 and one interval session, 3x/week on non-consecutive days

No clear difference in fatigue.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on fatigue in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 42 people found no clear difference; a small benefit can't be ruled out
  • Effect size 0.09 (very small)

How big was the difference?

0.09, very small. The effect size compares cardio / aerobic exercise with concurrent training (ct).

Studies with no comparison group21 in the study · 14 with outcome data · 10 weeks · 10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions

Fatigue improved.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on fatigue in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (14 in all)
See the 2 studies
  1. Exercise rehabilitation in post COVID-19 patients: a randomized controlled trial of different training modalities. (2025)

    People in the study
    66 randomised · 42 analysed
    Dose
    3x/week; 30min/session first two weeks, then two sessions at VT1 and one interval session, 3x/week on non-consecutive days
    Outcome
    FSS score Fatigue Severity Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    fatigue 7-Day Symptom Diary
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Anxiety1 study · 14 people took part in cardio / aerobic exercise Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (14 in all).

Studies with no comparison group21 in the study · 14 with outcome data · 10 weeks · 10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions

No clear change in anxiety.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on anxiety in long COVID. Little or no difference · very low certainty D

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (14 in all)
See the 1 study
  1. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    anxiety 7-Day Symptom Diary
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Post-exertional malaise1 study · 14 people took part in cardio / aerobic exercise Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (14 in all).

Studies with no comparison group21 in the study · 14 with outcome data · 10 weeks · 10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions

No clear change in post-exertional malaise.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on post-exertional malaise in long COVID. Little or no difference · very low certainty D

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (14 in all)
See the 1 study
  1. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    PEM score ≥ 2 modified DePaul Symptom Questionnaire—Post-Exertional Malaise
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

Daily life and health overall

Quality of life2 studies · 60 people took part in cardio / aerobic exercise Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (123 in all); the studies disagree; randomised trials found mixed results.

Randomised trials2 studies · 123 people with results

Studies disagree about quality of life.

Studies disagree about whether Cardio / aerobic exercise helps quality of life. Mixed results · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (123 in all)
  • The studies disagree
See the 2 studies
  1. Continuous versus low-intensity interval aerobic exercise in pulmonary rehabilitation after COVID-19. (2025)

    People in the study
    76 randomised · 63 analysed
    Dose
    40% of the peak workload, 15 sessions; 5-min warm up, 20-min exercise, 5-min cool-down period; three or five times a week
    Outcome
    SF36 physical function 36-item Short-Form Health Survey
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Effectiveness of endurance training rehabilitation after hospitalisation in intensive care for COVID-19-related acute respiratory distress syndrome on dyspnoea (RECOVER): a randomised controlled, open-label multicentre trial (2022) preprint

    People in the study
    60 randomised
    Dose
    two one-hour sessions per week, for 10 weeks
    Outcome
    Physical dimension 12-item Short-Form Survey (SF-12)
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
Daily functioning5 studies · 177 people took part in cardio / aerobic exercise Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; 244 people in all; a small benefit can't be ruled out; effect size 0.00 (very small).

Randomised trials3 studies · 244 people with results

No clear difference in daily functioning.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on daily functioning in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • 244 people in all; a small benefit can't be ruled out
  • Effect size 0.00 (very small)

How big was the difference?

0, very small. The effect size compares cardio / aerobic exercise with concurrent training (ct).

Studies with no comparison group2 studies · 34 people with results

Studies disagree about daily functioning.

Studies disagree about whether Cardio / aerobic exercise helps daily functioning. Mixed results · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (34 in all)
  • The studies disagree
See the 5 studies
  1. Exercise rehabilitation in post COVID-19 patients: a randomized controlled trial of different training modalities. (2025)

    People in the study
    66 randomised · 42 analysed
    Dose
    3x/week; 30min/session first two weeks, then two sessions at VT1 and one interval session, 3x/week on non-consecutive days
    Outcome
    Handgrip strength grip dynamometer
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Continuous versus low-intensity interval aerobic exercise in pulmonary rehabilitation after COVID-19. (2025)

    People in the study
    76 randomised · 63 analysed
    Dose
    40% of the peak workload, 15 sessions; 5-min warm up, 20-min exercise, 5-min cool-down period; three or five times a week
    Outcome
    Maximum load in exercise test (W)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  3. Medical Rehabilitation of Patients with Post-COVID-19 Syndrome-A Comparison of Aerobic Interval and Continuous Training. (2023)

    People in the study
    139 randomised
    Dose
    50% of maximal workload, 3–5 sessions/week; 18 min
    Outcome
    responder analysis at submaximal load
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    activity levels 7-Day Symptom Diary
    Effect
    no clear difference
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  5. Effects of Six Weeks of Supervised Telerehabilitation on Pulmonary Function, Functional Capacity, and Dyspnoea among individuals with Long COVID (2023) preprint

    People in the study
    20 in the study
    Dose
    40 minutes, three synchronous sessions per week
    Outcome
    6MWT six-minute walk test
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Overall symptoms3 studies · 61 people took part in cardio / aerobic exercise Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; one trial of 63 people found no clear difference; a small benefit can't be ruled out.

The randomised trial76 randomised · 63 analysed · 15 sessions · 40% of the peak workload, 15 sessions; 5-min warm up, 20-min exercise, 5-min cool-down period; three or five times a week

No clear difference in overall symptoms.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on overall symptoms in long COVID. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • One trial of 63 people found no clear difference; a small benefit can't be ruled out

Studies with no comparison group2 studies · 28 people with results

Overall symptoms improved.

The evidence is very uncertain about the effect of Cardio / aerobic exercise on overall symptoms in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (28 in all)
  • The paper's own effect size: 0.76 (Hedges’ g)
See the 3 studies
  1. Continuous versus low-intensity interval aerobic exercise in pulmonary rehabilitation after COVID-19. (2025)

    People in the study
    76 randomised · 63 analysed
    Dose
    40% of the peak workload, 15 sessions; 5-min warm up, 20-min exercise, 5-min cool-down period; three or five times a week
    Outcome
    Posttreatment outcome measures
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Exercise rehabilitation in post COVID-19 patients: a randomized controlled trial of different training modalities. (2025)

    People in the study
    66 randomised · 42 analysed
    Dose
    3x/week; 30min/session first two weeks, then two sessions at VT1 and one interval session, 3x/week on non-consecutive days
    Outcome
    Number of PCS symptoms
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  3. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID. (2024)

    People in the study
    21 in the study · 14 with outcome data
    Dose
    10 weeks of twice-weekly, 1.5 h, on-site aerobic training sessions
    Outcome
    overall health 7-Day Symptom Diary
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I

Side effects

Stopping because of side effects3 studies
Side effects studies reported4 kinds
Side effects studies reported, and how many studies reported each
Side effectStudies that reported it
Fatigue3 studies
Worse symptoms or a flare2 studies
Anxiety or irritability1 study
Headache1 study

All papers

  1. Exercise rehabilitation in post COVID-19 patients: a randomized controlled trial of different training modalities.2025 · randomised trial · 66 randomised · 42 analysed
    Summary

    This 3-arm, single-center randomized controlled trial enrolled 66 adults with post-COVID-19 syndrome (PCS) at least 12 weeks after laboratory-confirmed SARS-CoV-2 infection; participants were not hospitalized during acute COVID-19 and did not experience post-exertional malaise. People were randomized to 12 weeks of supervised endurance training (ED; N.=24), concurrent training (CT; N.=22), or a non-exercising control group (C; N.=20). Training took place 3x/week. Outcomes included VO2peak as the primary outcome, lower body and handgrip strength, heart rate variability, symptoms, health-related quality of life, and concentration performance. In total, 42 participants were analysed (N.=14 in each group). A significant time*group interaction for VO2peak favored both exercise conditions (ED: +3.9 mL/min/kg; CT: +3.2 mL/min/kg). Fatigue Severity Scale scores decreased in ED (Hedges’ g=0.63) and CT (Hedges’ g=0.82), but there was no time*group interaction (P=0.206). The number of PCS symptoms decreased in all groups, including the control group, and HRQoL improved in all groups. No significant main or interaction effects were found for concentration performance parameters. During the intervention, 10 ED, 8 CT and 6 control participants discontinued; 2 participants of the training groups stopped due to worsening symptoms in response to the intervention. The authors report an overall dropout-rate of 36,4%.

  2. Effect of water- and land-based exercise on lung function in children with post-COVID-19 condition: secondary results from a randomised controlled trial.2025 · randomised trial · 86 randomised · 74 analysed
    Summary

    This randomised controlled trial with a multigroup pre–post-test design included children aged 10–12 years with post-COVID-19 condition recruited from primary care clinics and schools in Warsaw, Poland. Of 86 children randomised, 74 completed the intervention; analysed group sizes were AQUA n=25, LAND n=23 and CONTROL n=26. AQUA received water-based exercise and LAND land-based exercise for 8 weeks, 2 days per week (16 sessions in total), each session 45 min; CONTROL received no exercise and was told not to change its routine. Lung function was measured with Lungtest Handy, including FEV1, FVC and VC, from baseline to immediately after the 8-week intervention. The paper reports significant GROUP×REPETITION interactions for absolute FEV1 (F(2,64)=6.80; p<0.01), FEV1 % pred (F(2,64)=6.96; p<0.01), FVC (F(2,64)=4.63; p<0.05) and FVC % pred (F(2,64)=4.99; p<0.01), but for FVC % pred there were no significant differences within or between groups. FEV1/FVC interaction was not significant (F(2,64)=0.71, p>0.05). Attendance was 84% in AQUA and 77% in LAND, with no significant difference. In CONTROL all spirometric parameters decreased (largest boys' FEV1% pred 11.3%; girls' FVC % pred 12%), but post hoc tests found no significant within-group differences. No adverse events were recorded; two new cases from the control group with restrictive disorders were found.

  3. Effectiveness of a 12-week telerehabilitation training in people with long COVID: A randomized controlled trial.2024 · randomised trial · 182 randomised
    Summary

    This parallel-group randomized controlled trial asked whether a 12-week telerehabilitation training program would improve outcomes in people with long COVID. Participants were recruited through a post-COVID Integrated Outpatient Clinic at a medical center in Northern Taiwan. Of 182 enrolled participants, 91 were assigned to telerehabilitation and 91 to control. The telerehabilitation group received 12 weeks of home-based training thrice per week for 40 min, using a mobile phone application connected to heart-rate-sensing clothing, with weekly remote monitoring. The control group received physical activity counseling only and maintained usual lifestyles for 12 weeks without exercise reminders. Outcomes were cardiorespiratory fitness (primary), physical activity amounts, exercise self-efficacy, sleep quality, and health-related quality of life, assessed at baseline and 12 weeks. The telerehabilitation group had greater walking behavior (b = −763.3, p < 0.001), total physical activity (b = −711, p = 0.003), exercise self-efficacy (b = −1.19, p < 0.001), and better sleep quality (b = 1.69, p = 0.012) than the control group. There were no significant differences in any cardiorespiratory fitness parameters or health-related quality of life at 12 weeks. One hundred twenty-two participants (67 %) completed data collection; 60 (EG 35; CG 25) did not return for the post-test. In the telerehabilitation group, 56 (62 %) completed the program, a dropout rate of 38 %. No participants completed the full 36 sessions; the average was 26.05 (74 %), and only 3 individuals surpassed 30 sessions. There were no significant adverse events; minor complaints were discomfort from tight intelligent clothes (n = 11), fatigue (n = 5), and delayed-onset muscle soreness (n = 2).

  4. Effect of Water-Based vs. Land-Based Exercise Intervention (postCOVIDkids) on Exercise Capacity, Fatigue, and Quality of Life in Children with Post COVID-19 Condition: A Randomized Controlled Trial.2023 · randomised trial · 86 randomised · 74 analysed
    Summary

    This three-group randomized controlled trial examined water-based exercise (AQUA), land-based exercise (LAND), and a no-exercise CONTROL in children aged 10–12 years with post COVID-19 condition, recruited from primary care clinics and schools in Warsaw (Poland). Of 86 children randomized, 74 (86%) completed the intervention and attended the post-intervention assessment. AQUA and LAND sessions were conducted twice a week, 45 min per session, for eight weeks. Exercise capacity was measured with the modified Balke treadmill protocol, fatigue with the CFSQ, and health-related quality of life with the PedsQL for children and parents. Absolute VO2max increased after AQUA (p = 0.001) and LAND (p = 0.004) but not CONTROL (p = 0.999); relative VO2max increased only in AQUA (p = 0.017). The only significant post-intervention VO2max difference was between AQUA and CONTROL (p = 0.023). No significant differences were found among groups for change in total fatigue or individual fatigue symptoms. The total PedsQL score reported by parents improved only in LAND (p < 0.01), with no between-group effect in children or parents. Mean attendance was 84% in AQUA and 77% in LAND, with no significant difference; no adverse events were recorded. The authors note a heterogeneous group and a relatively small sample size.

  5. Medical Rehabilitation of Patients with Post-COVID-19 Syndrome-A Comparison of Aerobic Interval and Continuous Training.2023 · randomised trial · 139 randomised
    Summary

    This randomized controlled trial at Clinic Königsfeld enrolled 139 PCS patients (per-protocol analysis 110) and compared continuous training (CT) with interval training (IT) during 4–6 weeks of inpatient medical rehabilitation. Patients performed cycle ergometer training 3–5 sessions/week for 18 min, CT at 50% of maximal workload and IT at 60% during load and 30% during recovery. Outcomes included symptom-limited cardiopulmonary exercise testing and questionnaires; PCS patients were also compared with 96 CAD patients. In the per-protocol comparison, peak oxygen uptake changed by 0.8 ± 11.2% for IT and 4.1 ± 10.8% for CT (p = 0.157), and submaximal oxygen uptake at VT1 changed by 0.3 ± 2.3 mL/min/kg for IT and 1.2 ± 2.7 mL/min/kg for CT with no difference. Participation in prescribed ergometer sessions was 89.5 ± 11.3% for IT and 94.9 ± 9.6% for CT (p = 0.012). Training workload increased by 11.0 ± 11.8 W for IT and 13.5 ± 13.7 W for CT (p = 0.307); total METs were 105.8 ± 30.9 for IT and 107.3 ± 33.0 for CT (p = 0.833). Responders were 56% for IT and 58% for CT at submaximal load (p = 0.835), and 51% for IT and 54% for CT at peak exercise (p = 0.836). Both groups showed reduced fatigue, anxiety, and depression and improved quality of life and wellbeing (all p < 0.05). No training-specific exercise-induced fatigue or PEM was detected. Withdrawals were not reported. Compared with CAD patients, ΔVO2peak was 2.7 ± 11.0% for PCS and 3.2 ± 12.1% for CAD (p = 0.796), while ΔW at VT1 was 10.5 ± 20.1 W (6.8 ± 12.1%) for PCS and 3.8 ± 20.0 W (2.1 ± 8.6%) for CAD (p = 0.011).

  6. Effectiveness of endurance training rehabilitation after hospitalisation in intensive care for COVID-19-related acute respiratory distress syndrome on dyspnoea (RECOVER): a randomised controlled, open-label multicentre trial2022 · randomised trial · 60 randomised · preprint
    Summary

    This multicentre, open-label, assessor-blinded randomised trial asked whether endurance training rehabilitation (ETR) reduces dyspnoea in adults with post-COVID-19-related acute respiratory distress syndrome (“long-covid”) who had been discharged from intensive care. It took place in three intensive care units in Paris, France. Sixty patients underwent randomisation: 27 to ETR and 33 to standard physiotherapy (SP). ETR was prescribed as two one-hour sessions per week for 10 weeks; SP was prescribed as two sessions per week for 10 weeks. The primary outcome was the Multidimensional Dyspnea Profile (MDP) at inclusion and after 90 days. At 90 days, mean MDP total score was 26.15 (SD 15.48) with ETR versus 44.76 (SD 19.25) with SP; mean difference -18.61 (95% CI -27.78 to -9.44; p<0.0001). Mean mMRC was 1.33 (SD 0.62) versus 2.09 (SD 1.10); mean difference -0.76 (95% CI -1.21 to -0.30; p=0.001). SF-12 total score difference was 8.24 (95% CI 0.22 to 16.25; p=0.14); physical dimension difference 6.95 (95% CI 2.62 to 11.29; p=0.016); mental dimension difference 2.06 (95% CI -3.63 to 7.75; p=0.72). Harms were not reported; the text states none withdrew consent after randomisation and none dropped out of the training program. The authors state limitations including a major challenge in referral to pulmonary rehabilitation practices.

  7. Autonomic conditioning therapy reduces fatigue and improves global impression of change in individuals with post-acute COVID-19 syndrome2021 · compared with another group · 94 in the study · 78 started · 78 with outcome data · preprint
    Summary

    This retrospective cohort analysis compared individuals with post-acute COVID-19 syndrome (PACS) referred to the Mount Sinai PACS Clinic who completed Autonomic Conditioning Therapy (ACT) for PACS with those who did not enroll. Of 94 individuals, 78 consented to have their data included in the analyses; 31 completed ACT for PACS and 47 did not enroll. ACT for PACS included 4 weeks of breath work coaching and 30-minute physical therapy sessions twice per week; median participation was 64 (21 to 137) days. Fatigue was measured with a fatigue visual analogue scale (VAS), and global impression of change with the Patient Global Impression of Change (PGIC). In the ACT group, fatigue VAS changed by -14 (95% CI -27 to -1), p = 0.03; the between-group difference was -13 (-30 to 5), p = 0.15. PGIC was 5 [1 to 7] with ACT and 4 [1 to 7] without ACT, p < 0.01. In the confirmed positive COVID-19 subgroup, PGIC was 6 [1 to 7] versus 3 [1 to 6], p < 0.01; in the negative/unknown subgroup it was 5 [1 to 7] versus 5 [1 to 7], p = 0.62. The text reports no within- or between-group differences in other outcomes, and no harm events or withdrawals due to harms. Authors state limitations include the non-randomized, retrospective design and possible self-selection.

  8. THE EFFECTS OF A MONITORED AEROBIC EXERCISE PROGRAM ON CHRONIC FATIGUE SYNDROME (CFS)2003 · compared with another group
    Summary

    Twenty-three CFS patients (CFS-TR) and 18 healthy, sedentary subjects (CON-TR) participated in a three day per week treadmill walking program for 10 weeks; training intensity progressed to 50% peak oxygen uptake during the last six weeks. Twelve CFS and seven CON were used for nontraining groups. All subjects performed a graded cardiopulmonary treadmill exercise test (CPX) pre and post 10 weeks. On each training day, feelings of well-being and ratings of muscle soreness were ascertained. Pre and post 10 weeks, CFS symptoms were assessed with questionnaires including the Multi-Fatigue Index, Medical Outcomes Study SF36, Profile of Mood States, and Beck Depression Inventory (BDI). Total CPX exercise time increased for the training groups (p < .04). Ratings of perceived exertion at absolute and relative workloads decreased for the CFS-TR (p < .05). Feelings of well-being and ratings of muscle soreness did not change for the CFS-TR (all p > .05). BDI scores for all CFS patients decreased over time (p < .05), but no significant changes were seen for additional symptom questionnaire variables (all p > .05). Two CFS-TR patients withdrew for reasons not attributed to symptom exacerbation. The authors concluded that CFS patients can tolerate mild to moderate aerobic exercise; training improved exercise tolerance but did not improve or exacerbate CFS symptoms. The abstract does not state limitations.

  9. A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life, and Immunologic Variables in Long COVID.2024 · no comparison group · 21 in the study · 14 with outcome data
    Summary

    Twenty-one participants with long COVID persisting more than 12 weeks after COVID-19 infection consented in this single-center pilot clinical trial; 14 completed a 10-week program of twice-weekly, 1.5 h supervised aerobic exercise training (20 sessions). There was no control group; participants were compared before and after training. Five people were excluded and referred for medical evaluation after abnormal screening tests, and two withdrew before training, one because of perceived increased PEM risk. Participants completed 96% of onsite visits, averaged 43 ± 9 min of exercise across all 20 sessions, and averaged 56 ± 7 min in the final session. Cardiorespiratory fitness, 6 min walk distance, quality of life, symptoms, 7-day activity, and immunologic variables were measured. After training, V.O2peak increased by 150 ± 200 mL/min (p = 0.017) or 1.51 ± 2.3 mL/kg/min (p = 0.030), and peak work rate increased 16 ± 20 watts (p = 0.010); 6 min walk distance, daily step count, and activity monitoring did not change significantly. SF-36 physical functioning, energy/fatigue, emotional well-being, social functioning, and general health improved; PHQ-9 depression scores fell significantly, GAD-7 anxiety was unchanged, and the FSS reduction was not statistically significant. Nine participants reported a PEM score ≥ 2 after training (64.3%), not different from baseline (p = 0.500). PESE/PEM occurred an average of 3 sessions out of 30 (range 0–7).

  10. Effects of Six Weeks of Supervised Telerehabilitation on Pulmonary Function, Functional Capacity, and Dyspnoea among individuals with Long COVID2023 · no comparison group · 20 in the study · preprint
    Summary

    This preprint reports a one-group pretest-posttest quasi-experimental study of a six-week supervised telerehabilitation program for 20 adults aged 18 to 75 years with long COVID discharged from the Physical Medicine and Rehabilitation Department in Al Ain hospital. All 20 participants completed six weeks of home-based aerobic training delivered remotely through Google Meet in three synchronous sessions per week; each session lasted 40 minutes, and participants were advised to perform physical activity for 30 minutes on the reminder days. There was no control group. Outcomes measured before and after included the six-minute walk test (6MWT), pulmonary function test (PFT: FVC, FEV1, FEV1/FVC, PEF), the modified Medical Research Council (mMRC) dyspnea scale, and the Global Physical Activity Questionnaire. The paper reported a 21% improvement in 6MWT, with pre 441.0 and post 534.0 meters (paired p .000). FVC was 3.15 pre and 3.29 post (p .000); FEV1 was 2.50 pre and 2.70 post (p .093); PEF was 6.31 pre and 7.04 post (p .000). FEV1/FVC was reported as a 1% increase in the results text, while the table showed 83.05 pre and 82.17 post (p .049). mMRC changed from 2.30 to 1.20 (p .000). Adherence was reported as over 90%. No adverse events were reported during the implementation of exercises. The authors state limitations including a single center, lack of control group, small sample size, overrepresentation of female, and lack of participant’s knowledge on web and technology literacy.

  11. Transcranial direct current electrical stimulation in combination with aerobic exercise is effective in reducing fatigue and pain in post-COVID-19 systemic autoimmune rheumatic patients2021 · no comparison group · 9 in the study · preprint
    Summary

    This single-center, prospective open-label one-arm study asked whether anodal tDCS combined with treadmill aerobic exercise would reduce fatigue and pain in patients with systemic autoimmune rheumatic diseases (SARDs) who had persistent or worsened fatigue or pain for more than 12 weeks after confirmed COVID-19 (post-COVID-19 syndrome). Nine patients were included and started treatment; no comparison group was randomised. Treatment was five daily sessions of anodal tDCS (2 mA, 20 minutes, over C3 or C4 with the cathode at Fp1 or Fp2) given together with treadmill walking for 30 minutes. Patients were assessed within one week before and one week after the protocol, with disease treatments unchanged. After the protocol, pain and fatigue VAS scores decreased significantly (P<0.05). Timed-up-go-test improved 9.5±2.7 vs. 6.8±0.8 (P=0.001) and sit-to-stand test 10.3±3.7 vs. 15.1±4.0 (P=0.037). No changes were observed in FACIT and MFIS fatigue scores and domains, though effect sizes were reported for FACIT and MFIS domains. Exercise intensity did not change (mean 5.5 ± 0.8) and perception of recovery remained unchanged. No subject experienced adverse events; there were no adverse effects of tDCS. One patient (#9) reported worsening of clinical joint symptoms after using tDCS, and patient #8 could not have her final data evaluated because she was in social isolation. Adherence was 100%. The authors state limitations of a limited sample size and lack of a control group.

  12. Relationship between Cardiopulmonary, Mitochondrial and Autonomic Nervous System Function Improvement after an Individualised Activity Programme upon Chronic Fatigue Syndrome Patients.2021 · no comparison group · 69 in the study · 53 started · 34 with outcome data
    Summary

    This activity-based study enrolled 69 people with CFS (Fukuda criteria), recruited through local and national TV and newspapers. Of these, 53 started a 16-week Individualised Activity Programme (IAP), a home-based programme performed 5 days a week with time (10–40 min) and intensity (30–80% HRpek) increasing gradually. Thirty-four patients (20 females, 14 males) completed IAP. No control group was recruited. Fatigue was measured with CFQ, FSS and FIS; cardiorespiratory function with CPET; mitochondrial markers Mfn1 and Mfn2 in plasma; and autonomic function with a Task Force Monitor at rest and during HUTT. In completers, CFQ decreased from 26.12 to 9.68 (p < 0.001), FSS from 48.91 to 40.15 (p < 0.0001), and FIS from 93.59 to 61.68 (p < 0.0001). VO2peak increased from 30.3 to 31.79 mL/kg/min (p = 0.047). Mfn1 increased from 0.22 to 0.33 ng/mL (p = 0.002) and Mfn2 from 5.51 to 8.05 ng/mL (p = 0.00005). Autonomic nervous system function indicators were not significant. Mean compliance was 80%; only 1 patient reached 80% HRpeak during the last training session, 32 reached 70% HRmax, and 1 achieved 60%HRpeak. Nineteen patients dropped out due to severe PEM; the authors report a withdrawal rate of 35 from 69 patients and that exercise was not well tolerated by 51% of patients. Limitations stated were no control group, PEM not measured, and small sample size.

  13. A Case Study of Successful Application of the Principles of ME/CFS Care to an Individual with Long COVID.2023 · case report · 1 in the study
    Summary

    This case study reports a 19-year-old male who developed impairment consistent with ME/CFS after SARS-CoV-2 infection. The study reports one patient; there was no comparison group, and outcomes were before-versus-after over 30 months. Treatment included physical therapy; stationary biking and running as graded activity; oral sodium chloride and lower limb compression garments; and medications/supplements: fludrocortisone, midodrine, atenolol, pyridostigmine bromide, ivabradine, clonidine, methylphenidate, fexofenadine, famotidine, cromolyn, quercetin, escitalopram, and naltrexone. The paper reports significant improvement in symptoms over 30 months. With cromolyn, peak walking heart rate fell from the 130–140 bpm range to 100–105 bpm. Stopping fexofenadine and famotidine was accompanied on more than one occasion by increased fatigue and cognitive dysfunction; stopping H1 and H2 antihistamines was associated with worsened concentration and short-term memory. Naltrexone was associated with improved energy and overall function, and the patient reported improvements with low doses of clonidine and methylphenidate. For the first 15 months after infection, he continued to have exercise intolerance, with heart rate reaching 130–150 bpm during each of two 15-min walks daily. At one year, remaining symptoms included daily fatigue; lightheadedness and headaches were infrequent. He later resumed running at 10 min four times a week, increased running by two minutes each week, and in October 2022 competed in an 8 K event. Adverse effects were reported with fludrocortisone, midodrine, atenolol, pyridostigmine bromide, and ivabradine. Limitations stated include possible spontaneous improvement and uncertainty about independent effects of interventions.

  14. Corona With Lyme: A Long COVID Case Study.2023 · case report · 1 in the study
    Summary

    This case report describes a previously healthy 26-year-old female medical student living in New York, NY, who developed long COVID after a presumed acute SARS-CoV-2 infection in March 2020, with a concurrent perceived early-disseminated Lyme disease infection. The three-year arc covers numerous trial-and-error treatments: a two-week regimen of doxycycline 100 mg twice a day, metformin escalation alongside diet modifications, graded compression stockings, breathing exercises, increases in caffeine and salt consumption with increased fluid intake, a horizontal cardio exercise program with rest periods, osteopathic manipulative treatment, cognitive behavioral therapy, sleep hygiene improvements, supplements (vitamin C, vitamin D, vitamin B12, B-complex, n-acetyl cysteine, turmeric extract), a two-dose Moderna mRNA COVID-19 vaccination course, and abortive headache therapies (Excedrin or Fioricet and prochlorperazine). The authors report a moderate reduction in cycle length and morning hypoglycemic symptoms with metformin, a moderate reduction in myalgias, headaches and scalp allodynia with osteopathic manipulative treatment, some relief of post-COVID headache, help with headache pain, orthostatic palpitations, fatigue and brain fog from abortive therapies plus caffeine, salt and fluid intake, moderate improvements in fatigue and brain fog in the first 24 hours after the first vaccine dose, moderate symptom alleviation from digital interventions, and small but recognizable differences in fatigue and cognition from sleep hygiene. No improvement in symptoms other than mild reduction in right shoulder pain followed the doxycycline regimen. Supplements provided no discernable benefit. The patient reports full recovery from long COVID with residual blurred vision and oligomenorrhea. Reported harms include worsening blurred vision, palpitations, heat intolerance and near-syncopal events; a moderate increase in fatigue and brain fog with a CGRP antagonist; fatigue exacerbation with traditional exercise rehabilitation; symptom re-exacerbations with compression stockings; and increased headache frequency and duration with n-acetyl cysteine. The abstract describes near-total remission.

  15. Excessive eating and weight gain:A rare post-acute COVID-19 syndrome.2021 · case report · 1 in the study
    Summary

    This case report described why the authors reported a rare occurrence of polyphagia following acute COVID-19 illness. The patient was one 41-year-old female who had fully recovered from acute COVID-19 pneumonia six months prior and was referred by her primary care physician at the COVID-19 treatment to a psychiatric facility. She received psychotherapy and behavioral management for polyphagia, including creating a timetable for eating and taking caffeine instead of porridge; treatment duration was not reported. There was no comparison group. The report measured appetite and BMI. By the time of writing, the patient reported a mild decrease in her appetite, and BMI was maintained. Harms and withdrawals were not reported. The authors concluded that polyphagia may be one of the rare post-acute COVID-19 syndromes and requires further research. They stated that more studies are warranted to understand the etiology, diagnosis, and management of post-acute COVID-19 syndrome-related polyphagia, and that the role of pharmacological drugs may require further studies.

  16. Effectiveness of physical, psychological, and alternative interventions for post-COVID-19 condition: a systematic review.2026 · systematic review
    Summary

    This systematic review asked whether supervised physical, psychological and alternative non-pharmacological treatments help adults with post-COVID-19 condition. It included 27 randomized trials with 1,998 participants; trials were supervised and face-to-face and compared interventions with usual care, placebo/sham or active comparators. Interventions included cardiopulmonary rehabilitation, multimodal and unimodal exercise, CBT and lifestyle programmes, neuromodulation, oxygen therapies, acupuncture and balneotherapy. Intervention durations varied. The review reported that cardiopulmonary rehabilitation and multimodal exercise consistently improved cardiorespiratory fitness and walking capacity; CBT and lifestyle adjustments significantly reduced fatigue and subjective concentration complaints. Examples recorded: in 114 participants, CBT lowered CIS-fatigue by a between-group mean difference of −8.8 points (95% CI −11.9 to −5.8); in 70 participants, active HD-tDCS plus rehabilitation lowered MFIS total fatigue by a between-group difference of −14.03 points (95% CI −20.28 to −7.78). Findings for neuromodulation, complementary and oxygen therapies were heterogeneous, often showing no benefit over placebo. For example, HBOT did not produce significantly greater improvements than sham on any primary or secondary outcome. Side effects and withdrawals were not reported in the recorded data. The authors state that the evidence does not support definitive conclusions about the effectiveness of any intervention category.

  17. Effectiveness of Non-Pharmacological Interventions for Fatigue in Long COVID: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2026 · systematic review
    Summary

    This systematic review and meta-analysis included 13 RCTs with 1276 participants with long COVID. It compared non-pharmacological interventions—exercise training, cognitive behavioural therapy, non-invasive neuromodulation, and nutritional supplementation—with control conditions. Fatigue severity was assessed with validated instruments. The review reported that exercise training was the only modality associated with a statistically significant reduction in fatigue. For CBT, non-invasive neuromodulation, and nutritional supplementation, the review did not observe a statistically significant pooled effect. The difference in effects between intervention modalities was not statistically significant (p = 0.286). Harms were reported in several trials: two participants discontinued the exercise intervention (transient worsening of fatigue), and 2 participants of the training groups stopped (worsening of their symptoms in response to the intervention). In one trial there were eight AEs (four PEM, two musculoskeletal issues, one nausea and one atypical chest pain) and one unrelated SAE. In another, eight of the sixteen patients receiving active tDCS and nine of the seventeen assigned to sham tDCS experienced mild to moderate side effects such as burning or tingling. The review notes that overall certainty is low to moderate, with substantial between-study heterogeneity and limited RCTs for non-exercise interventions.

  18. Effects of different exercise training modalities in post-COVID-19 individuals: a systematic review of randomized controlled trials.2026 · systematic review
    Summary

    This systematic review of randomized controlled trials examined exercise training for adults with post-COVID-19 syndrome across multiple countries. Eighteen RCTs (N = 1171) were included, and a total of 1171 participants completed the analyses. Follow-up durations ranged from 4 to 16 weeks. The interventions were aerobic training (AT), high-intensity interval training (HIIT), or combined training (CT), compared with usual care (UC). Outcomes included functional capacity (VO2peak and 6MWT), muscle strength, quality of life, anxiety, depression, and CPET-derived parameters. Structured exercise training was associated with improvements in functional capacity and muscle strength, although not all trials showed significant differences versus UC. HIIT showed the largest within-group VO2peak improvement (mean difference 6.17 ml.kg−1.min−1), with no significant difference versus UC. Bai et al. found a significant VO2peak increase versus UC (mean change 4.64 vs −1.06 ml·kg−1·min−1; p = 0.001). Effects on quality of life, anxiety, and depression were inconsistent. Most cardiopulmonary parameters showed no significant changes, with mixed results for O2 pulse and ventilation. Bai et al. reported dizziness/fatigue and occasional ventricular and atrial premature beats, with all completing the study; Daynes et al. reported two adverse events, both unrelated to the intervention; de Moraes Sirydakis et al. listed exercise hypotension and glucose changes. The authors state substantial heterogeneity precluded meta-analysis.

  19. Exercise effectiveness on fatigue in Long-COVID: systematic review and meta-analysis.2026 · systematic review
    Summary

    This systematic review and meta-analysis examined exercise for fatigue in adults with Long COVID (symptoms ≥3 months). The authors searched 7 databases in July 2025 and included 14 randomized controlled trials. Exercise groups were compared with usual care. In pooled analyses, the exercise group increased grip strength by 3.86 kg (MD 3.86 kg, 95% CI 2.23-5.50; P < .00001), respiratory muscle strength by 15.54 cmH2O (MD 15.54 cmH2O, 95% CI 8.73-22.34; P < .00001), and 6-minute walk distance by 93.57 m (MD 93.57 m, 95% CI 60.34-126.80; P < .00001). Sit-to-stand repetitions increased (SMD 1.43, 95% CI 0.40-2.46; P = .006) and sit-to-walk speed decreased by 1.23 s (SMD −1.23, 95% CI −2.11 to −0.34; P = .007). The exercise group reduced dyspnea incidence (RR 0.33, 95% CI 0.19-0.56; P < .0001), dyspnea severity (SMD −0.89, 95% CI −1.52 to −0.27; P = .005), fatigue incidence (RR 0.45, 95% CI 0.28-0.74; P = .002), and fatigue severity (SMD −0.59, 95% CI −0.96 to −0.21; P = .002). Subgroup analyses for fatigue severity found multimodal exercise reduced fatigue severity (SMD −0.45, 95% CI −0.85 to −0.06; P = .03), whereas single-modality exercise did not (SMD −0.84, 95% CI −1.71 to 0.03; P = .06). Attrition rates ranged from 0% to 30.38%; no adverse events were reported in the included studies, but most trials provided limited information regarding PEM monitoring and adverse event ascertainment. The authors describe the certainty of evidence as moderate to very low.

  20. Effectiveness and safety of exercise therapy in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a meta-analysis.2025 · systematic review
    Summary

    This meta-analysis asked whether exercise therapy changes fatigue and harms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The authors searched PubMed, Web of Science, Embase, and Cochrane to March 2024, with an update on June 7, 2025, and analyzed 13 studies with 1,305 patients: 659 in intervention groups and 646 in control groups. Interventions included aerobic training, guided graded exercise self-help, graded exercise therapy, gradual exercise, and Qigong forms. Control conditions included control, standard medical care, adaptive pacing therapy, CBT, and heart rate variability biofeedback. Outcomes were fatigue scale-14 (FS-14), multidimensional fatigue inventory (MFI-20), and adverse effects. The meta-analysis reported lower total, physical, and mental fatigue scores on FS-14 with exercise therapy than control; on MFI-20, physical fatigue and reduced activity improved, while general fatigue, mental fatigue, and reduced motivation did not differ significantly. Subgroup analysis reported conventional exercise was more favorable for total and physical fatigue, while Qigong was more favorable for mental fatigue. For harms, Clark et al. reported non-serious adverse events in ~1/4 of participants in both the intervention group and the control group, one case of serious adverse events in both groups, and no serious adverse reactions in either group; severe deterioration difference was not evident. Another study reported non-serious adverse events frequently, serious adverse events and severe adverse reactions relatively rare, and severe deterioration uncommon. The authors note publication bias and limitations.

  21. Dropouts in Exercise Rehabilitation Program in Patients With Long COVID: A Systematic Review.2025 · systematic review
    Summary

    Objective: to describe dropout rates, reasons, and factors associated with dropout during rehabilitation programs for patients with long COVID. The review included 23 studies with 1,523 patients with long COVID (mean age 53.0 ± 6.4 yrs; 51% female). Eligible programs were exercise interventions lasting at least 4 weeks for patients aged 18 or older of both sexes. The review did not compare one exercise regimen against another; it pooled dropout data and compared dropout ratios across study variables. The main outcome was dropout rate, recorded as absolute numbers and frequency, and the secondary outcome was reasons for dropout. Of 1,523 patients enrolled, 216 withdrew, constituting 14.2% of the total sample. Grouped dropout reasons were not reported (31.0%), health issues (23.1%), did not complete assessments (19.4%), loss of interest (15.7%), lack of adherence (6.9%), and adherence to other interventions (3.7%). Individual included studies listed side effects (n = 5), symptoms exacerbation (n = 1), musculoskeletal issue (n = 1), other acute health conditions (n = 2), and hospitalization (n = 1) as dropout reasons. The review reports no significant associations between dropout rate and remaining variables. The authors state that dropout rates were 14% and that health-related issues and incomplete assessments were the most common reasons.

  22. Effects of therapeutic interventions on long COVID: a meta-analysis of randomized controlled trials.2025 · systematic review
    Summary

    This meta-analysis pooled 51 RCTs with 4026 participants with Long COVID, searching PubMed, Cochrane Library, Embase, Web of Science, SPORTDiscus (EBSCO), CINAHL (EBSCO), and Rehabilitation & Sports medicine source (EBSCO) to July 20, 2025. Trials compared exercise training, respiratory muscle training, telerehabilitation, tDCS, olfactory training, steroid sprays, or PEA-LUT with no intervention, standard primary care, or placebo; follow-up ranged from 14 to 180 days. Outcomes included cardiopulmonary function, exercise capacity, fatigue, dyspnea, and olfactory recovery. Exercise training showed significant better 6MWT (MD 83.20; 95% CI 52.04–114.37) and 30sSTS (MD 3.05; 95% CI 1.96–4.13), but no significant difference for HADS-depression, HADS-anxiety, SF-12-PCS, FVC (% predicted), FEV1, VE/VO2, VE, RER, or FEV1/FVC. Respiratory muscle training showed significant better 6MWT (MD 89.54; 95% CI 9.86–169.23) and MIP (cm H2O) (MD 19.69; 95% CI 10.14–29.24), with no significant difference for FVC, FEV1, MFIS, HADS, or MEP. Telerehabilitation showed significant better 6MWT (MD 34.14; 95% CI 2.54–65.74), 30sSTS (MD 1.41; 95% CI 0.67–2.15), and FSS (MD −1.59; 95% CI −2.64 to −0.53). tDCS showed significant lower MFIS-physical (MD −2.29; 95% CI −4.36 to −0.22). Olfactory training and steroid sprays showed no significant differences; PEA-LUT showed significant higher TDI Score (MD 4.66; 95% CI 2.16–7.15). No side-effect or withdrawal counts were reported; the authors noted exercise may pose a risk of symptom exacerbation in post-exertional malaise. They reported high risk of bias in 33 studies and high heterogeneity.

  23. Effect of nonpharmacologic therapies on depressive symptoms in patients with chronic fatigue syndrome: a network meta-analysis.2025 · systematic review
    Summary

    This network meta-analysis examined nonpharmacologic therapies for depressive symptoms in patients with chronic fatigue syndrome (CFS). The authors searched PubMed, Cochrane Library, Web of Science, Embase, CNKI, Wanfang, CBM, VIP, and Sinomed for randomized controlled trials until March 26, 2025, and included 47 RCTs involving 4,028 participants. The review compared nonpharmacologic interventions with control conditions and measured depression or depressive symptoms with scales. Compared with control, the review reports significant differences for acupuncture (SMD = -1.91, 95% CI: -2.9 to -0.94), moxibustion (SMD = -2.91, 95% CI: -4.61 to -1.22), Tuina (SMD = -2, 95% CI: -3.64 to -0.38), diet therapy (SMD = -5.64, 95% CI: -8.98 to -2.29), electrical stimulation (SMD = 1.9, 95% CI: 0.03 to 3.78), Ap + Mox (SMD = 2.53, 95% CI: 1.17 to 3.91), and Ap + Mox + Ae (SMD = 3.16, 95% CI: 0.39 to 5.98). The review states that relaxation therapy, AER, RT, and Qigong did not markedly improve depressive symptoms, and psychotherapy did not show significant effects. Harms were not reported as counts; the review includes a statement that graded exercise therapy may exacerbate symptoms in certain CFS patients, a statement about exercise therapy, the patient’s energy limit, characteristic post-exertional malaise (PEM), and efficacy, and a statement that Tuina has no adverse reactions. The authors state heterogeneity, inconsistent depression scales, and medium risk of bias in most included studies, with some interventions from few small studies, so results should be viewed with caution.

  24. Clinical efficacy of exercise in the treatment of post-COVID-19 syndrome: a systematic review and network meta-analysis.2025 · systematic review
    Summary

    This systematic review and network meta-analysis asked whether exercise therapy helps post-COVID-19 syndrome (PCS), described as persistent or new symptoms beyond the acute phase of SARS-CoV-2 infection. The authors searched PubMed, Embase, Web of Science, and Ovid through 25 March 2025 and included 33 randomized controlled trials with 2,895 participants. Exercise interventions were grouped as aerobic exercise (AE), respiratory muscle training (RMT), resistance training (RT), combinations, or no exercise therapy. Outcomes included FEV1/FVC, peak VO2, six-minute walk test (6MWT), mMRC dyspnea score, and Mental Health/Mental Component Summary scores. For FEV1/FVC, AE + RMT ranked highest (97.62%), followed by AE (76.33%) and RMT (40.62%); the text states AE + RMT was better than the other treatments except AE, while AE was better than no exercise therapy. For peak VO2, the experimental group had a statistically significant reduction compared with control (Z = 3.02, P = 0.003; I2 = 0%). The 6MWT distance showed a statistically significant advantage for the experimental group (Z = 6.13, P < 0.00001; I2 = 83%), and AE + RMT + RT was better than no exercise intervention (Z = 14.26, P < 0.00001; I2 = 0%). mMRC was better in the experimental group (Z = 2.88, P = 0.004; I2 = 95%). MH (Z = 2.63, P = 0.008; I2 = 0%) and MCS (Z = 4.09, P < 0.0001; I2 = 10%) were significantly better in the experimental group than in the control group. No difference, worsening, stopping, or side-effect counts were reported in the text provided.

  25. Effects of Physical Exercise on Functional Physical Performance in Individuals With Long COVID: A Systematic Review.2025 · systematic review
    Summary

    This systematic review asked whether physical exercise changes functional physical performance in people with long coronavirus disease-2019 (COVID-19). Seven studies were reviewed; interventions lasted 2 to 16 weeks, with frequencies of 2 to 7 days per week. Search databases included MEDLINE, EMBASE, Web of Science, Scielo, SPORTDiscus and CINAHL. The included studies compared exercise programmes with control conditions such as standard physiotherapy, usual care, home rest, medical care and advice, or home-based guidelines. Outcomes covered strength, cardiorespiratory fitness, agility/mobility, anxiety, depression, quality of life, dyspnea and fatigue. Strength improved in 67% of studies, cardiorespiratory fitness in 50%, and agility/mobility in 60%. Anxiety improved in 25% of studies, depression in 75%, and quality of life across all studies (5 out of 5). Dyspnea improved in 40% and fatigue in 80% of studies. Adverse effects were assessed in five studies, which did not report their occurrence. Worsening and stopping were not reported. The authors conclude that results suggest potential benefits of exercise training in several outcomes, mainly functional capacity, depression symptoms, quality of life and fatigue. They state limitations: the studies evaluated show a varied population, including hospitalized and non-hospitalized individuals; the absence of a standardized therapeutic protocol with interventions of varying duration makes it difficult to understand the effects; and the small sample size restricts generalization and the ability to detect significance.

  26. Non-Invasive Brain Stimulation for Post-COVID-19 Conditions: A Systematic Review.2025 · systematic review
    Summary

    This systematic review asked whether non-invasive or minimally invasive brain stimulation reduces symptoms of post-COVID-19 condition. Four databases were searched through April 2nd, 2024; 19 studies were included, covering tDCS, TMS, tVNS and toACS. Across the included studies, Klirová et al. (33 patients) found no significant intergroup difference in post-COVID-19 symptoms. Santana et al. (70 patients) reported a significant reduction in fatigue and anxiety and an improvement in quality of life with active HD-tDCS compared with sham. Oliver-Mas et al. (47 patients) reported a significant improvement of physical fatigue and depressive symptoms in the active tDCS group compared with sham. Gracia et al. (15 patients) found no significant improvement across groups. Vestito et al. (7 patients) reported a significant improvement of hyposmia comparing tDCS with sham. Sakib et al. (4 patients) detected no significant group differences for rTMS. Badran et al. (13 patients) reported a trend towards mild to moderate effects of tVNS on fatigue. Reported harms included transient burning or tingling during tDCS, mild and transient headache and dizziness, transient tingling on the scalp, transient mild skin irritation with tVNS, and transient pain at the TMS stimulation site. The authors state that sample sizes are small, many studies are case reports, randomization and control groups are often missing, and diagnostic criteria differ.

  27. Comparative efficacy of various exercise therapies for chronic fatigue syndrome: A systematic review and network meta-analysis.2025 · systematic review
    Summary

    This systematic review and network meta-analysis asked whether exercise therapies help chronic fatigue syndrome (CFS). The review included 25 randomized controlled trials; 20 trials (n = 2,831) were eligible for network meta-analysis, and 3,602 patients with CFS were included overall. Exercise modalities were GET, Qigong, Yoga, strength/resistance training, and running, compared with waitlist, specialist medical care, or relaxation/flexibility. Outcomes were fatigue, depression, anxiety, physical function, and sleep quality. For fatigue at the end of treatment, GET compared with waitlist had MD −6.93 (95% CI −10.85 to −3.01; moderate certainty); Qigong MD −5.02 (95% CI −9.79 to −0.25; low certainty); running MD −9.66 (95% CI −18.20 to −1.12; very low certainty); strength/resistance training MD −5.79 (95% CI −14.17 to 2.58; very low certainty); Yoga MD −3.89 (95% CI −12.89 to 5.11; very low certainty). For depression, GET MD −5.27 (95% CI −7.38 to −3.16; low certainty). For anxiety, GET MD −2.88 (95% CI −5.10 to −0.66; low certainty). For physical function, GET MD 6.41 (95% CI 4.87 to 7.96; moderate certainty), and Qigong MD 2.30 (95% CI −0.77 to 5.37; low certainty). For sleep, GET MD −2.32 (95% CI −4.35 to −0.29) and Qigong MD −1.30 (95% CI −2.44 to −0.16), both low certainty. The authors state that physical function and sleep improvements remained below clinically meaningful thresholds. The text mentions symptom exacerbation in 'some patients' but gives no count for this review.

  28. Effectiveness of Exercise-Based Rehabilitation in Chronic Fatigue Syndrome: A Systematic Review and Meta-analysis.2025 · systematic review
    Summary

    This systematic review and meta-analysis asked whether exercise-based rehabilitation improves fatigue and functional capacity in adults with CFS compared with conventional treatment. Setting was not reported. 11 studies were included in the qualitative review, and 7 randomized controlled trials (n = 2,276 participants) were included in the meta-analysis. The programs included aerobic training, resistance exercises, GET, Qigong, and multimodal interventions; outcomes were grouped as short-term (< 3 months), medium-term (3 to 6 months), and long-term (≥ 6 months). For short-term fatigue, the review reported n = 720, SMD = −0.49, 95% CI [−0.75, −0.24], p = 0.0001. Short-term functionality was n = 685, SMD = 0.09, 95% CI [−0.05, 0.249], p = 0.20, with the effect slightly favoring control and not reaching significance. Medium-term fatigue was n = 501, SMD = −0.53, 95% CI [−0.947, −0.119], p = 0.01. Medium-term functionality was n = 366, SMD = 0.31, 95% CI [0.105, 0.517], p = 0.003, and the text states exercise therapy did not show improvement compared with conventional treatments. Long-term fatigue was n = 531, SMD = −0.07, 95% CI [−0.517, 0.365], p = 0.74; long-term functionality was n = 421, SMD = 0.03, 95% CI [−0.473, 0.536], p = 0.90. Adverse-event reporting was inconsistent. Worsening and stopping were not reported. Authors state low to moderate certainty and weak recommendation.

  29. Post-Acute COVID-19 Syndrome (PACS) and Exercise Interventions: A Systematic Review of Randomized Controlled Trials.2025 · systematic review
    Summary

    This systematic review asked whether exercise interventions affect health-related quality of life and functional fitness in adults with Post-Acute COVID-19 Syndrome. It searched databases and clinical registers up to July 2025 and included 20 randomized controlled trials. Exercise programmes varied: aerobic training, resistance or concurrent training, breathing exercises, strength-based exercises, pilates, yoga disciplines and telerehabilitation; one study used continuous aerobic training at 50% of workload. Durations included a 2-week protocol and an 8-week protocol. Comparators included usual care, waitlist, no intervention, general guidance, another exercise setting or another exercise delivery. Outcomes were HRQoL and functional fitness. Some trials reported significant HRQoL improvements (Refs. [30,39,46]) and positive SF-12 physical and mental components (Refs. [27,29,35]). Ref. [32] found no significant quality-of-life change between supervision by a general or specialized physiotherapist, though the SF-12 physical component changed. Ref. [33] found virtual reality was not superior to traditional methods. Ref. [31]’s 2-week breathing- and strength-based protocol and Ref. [41]’s 8-week breathing, pilates and yoga protocol were described for respiratory function. Overall dropout rates were below 37%; treatment-attributed harms were not reported. The authors state limits include heterogeneity of protocols and non-comparable frequency, duration, and modality.

  30. Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials.2025 · systematic review
    Summary

    This systematic review and meta-analysis asked whether pulmonary rehabilitation affects adults with long COVID-19. The authors searched randomized controlled trials published before April 2024 and included 37 studies with 3363 patients. Pulmonary rehabilitation was compared with controls receiving usual care, no treatment, educational material, a sham device, or unsupervised rehabilitation. Programs were grouped by duration (≤4, 4–8, and >8 weeks) and by exercise type (breathing, multicomponent, or both). Outcomes included 6MWT, lung function (FEV1, FVC, MIP, MEP), HRQoL, fatigue, 30STST, handgrip, dyspnea, depression, anxiety, perceived effort, and adverse events. The review reports improvement in 6MWT with a mean difference of 77.95 m (95% CI 50.91–104.99 m), and improvements in 30STST, handgrip, lung function, HRQoL, fatigue, dyspnea, and anxiety, but no effect on depression was detected. Subgroups: ≤4 weeks improved 6MWT but not FEV1, FVC, HRQoL, or fatigue; 4–8 weeks improved 6MWT, FEV1, FVC, HRQoL, and fatigue; >8 weeks improved HRQoL and fatigue but no additional 6MWT, FEV1, or FVC. Breathing exercises improved 6MWT, lung function, and HRQoL without fatigue effect; multicomponent exercises improved 6MWT and fatigue without lung function or HRQoL effects; combined exercises improved 6MWT, FEV1, FVC, HRQoL, and fatigue. Adverse events were reported in 16 RCTs: nine found none in either group; two reported events in both groups; one reported minor oxygen desaturations in the intervention group; three reported control-group events; one reported reinfection without specifying group. GRADE certainty was low to moderate, and the authors state bias may have overestimated outcomes.

  31. Physical Training Protocols for Improving Dyspnea and Fatigue in Long COVID: A Systematic Review with Meta-Analysis.2025 · systematic review
    Summary

    This systematic review with meta-analysis asked which physical training protocols are used by people with long COVID to alleviate dyspnea and fatigue. The search was conducted in October 2023; 25 articles were included. The review included primary experimental studies of individuals living with long COVID; its comparison was “not applicable.” Training protocols were mostly combinations of methods, most commonly respiratory muscle training with strength and aerobic training. Other protocols included concurrent training, inspiratory muscle training (IMT), concurrent training with IMT, a self-directed program following WHO recommendations, and aerobic training alone. The text does not report a single duration for these protocols. Dyspnea and fatigue were assessed with questionnaires. Of the 17 studies that assessed dyspnea, 11 showed significant improvement after physical exercise rehabilitation; of the 20 that assessed fatigue, 10 showed significant improvement after physical training. A meta-analysis of two studies found no significant effect on reducing fatigue compared with the control group (intervention participants: 37; control: 38; 95% CI: 15.42 to 8.77; I2: 89%). A study showed periods of worsening fatigue and dyspnea as a fluctuating pattern, and in some sessions an increase in fatigue and dyspnea intensity after excessive effort. Stopping and side effects were not reported. The authors state most studies had a moderate to high risk of bias and heterogeneity limited a more comprehensive meta-analysis.

  32. Identifying Factors That Might Affect Outcomes of Exercise-Based Therapies in Long-COVID.2024 · systematic review
    Summary

    This systematic review examined exercise-based therapies for people with Long-COVID; it included 39 studies. The search was performed from 13 February 2024 to 27 February 2024 in Pubmed, PEDro, BioMed Central, EBSCOhost, ProQuest and the ZBSport. Treatments included supervised exercise training and programs combining physical training with respiratory training, pacing or physiotherapy; some combined programs lasted >5 weeks with three individualized sessions per week. The review reports no comparison group. Outcomes covered Long-COVID symptoms, quality of life, physical fitness and pulmonary parameters. In one named study (Binetti et al.), a 3-month protocol showed no significant improvements in Long-COVID symptoms or physical fitness. Adverse events were documented in 16 studies: no adverse events were identified in 12/16 studies, and 4/16 studies reported adverse events related to the intervention. One study recorded 6–9% adverse events and 2–5% serious adverse events in the intervention and usual care groups; 21 serious adverse events and 19 admissions to hospital or prolongation of admission were reported, and one serious adverse event (syncope with vomiting 24 h after training) was possibly related to the intervention. Intervention-related adverse events included unilateral knee pain, severe anxiety before the session and headache. In a pacing study, four patients were unable to comply with guidance. There were no cases of exacerbation of symptoms after exercise during weekly monitoring. The authors state that comparison was difficult because the same parameters were examined using a wide variety of measurement methods.

  33. An update of the literature about rehabilitation tools used in the treatment of COVID-19-related disabilities: a systematic review of literature.2024 · systematic review
    Summary

    This systematic review aimed to describe the effects of rehabilitation tools used across phases of COVID-19. A literature search of MEDLINE (PubMed), Scopus and Physiotherapy Evidence Database (PEDro) was conducted. The review included 2994 participants: 1225 patients for acute-COVID, 1331 patients for post-COVID, and 438 patients for long-COVID. Of the initial 907 hits, 45 randomized controlled trials were included. The trials studied respiratory rehabilitation alone or with exercises, tele-rehabilitation, endurance training, virtual reality, and electrostimulations in different settings and phases of infection. Outcomes were clinical, quality of life and impairment outcome measures. The text does not report a comparison group, treatment duration, withdrawals, worsening, or side effects for the review. The authors concluded that, despite heterogeneity, different outcome measures and small sample sizes, pulmonary rehabilitation, tele-rehabilitation and low/moderate intensity aerobic and endurance exercises seemed to improve clinical and quality of life outcomes at short (8 weeks) and mean time (2 months) after treatments in all phases of the infection.

  34. Interventions for the management of long covid (post-covid condition): living systematic review.2024 · systematic review
    Summary

    This living systematic review assessed drug and non-drug interventions for long covid in adults. It included 24 unique trials with 3695 patients, predominantly from the Americas or Europe. One trial (n=114) compared an online CBT programme called “fit after covid” with usual care; moderate certainty evidence suggested CBT probably reduces fatigue (mean difference −8.4, 95% CI −13.11 to −3.69) and probably improves concentration (mean difference −5.2, −7.97 to −2.43). One trial (n=585) compared combined physical and mental health rehabilitation with one session of online advice and support; moderate certainty evidence suggested it probably increases recovery or important improvement (161 more per 1000 patients, 95% CI 61 more to 292 more), improves quality of life (mean difference 0.04, 95% CI 0.00 to 0.08), and reduces depression (mean difference −1.50, −2.41 to −0.59), with little or no effect on physical and cognitive function or anxiety. Intermittent aerobic exercise 3-5 times weekly for 4-6 weeks probably improves physical function compared with continuous exercise (mean difference 3.8, 95% CI 1.12 to 6.48; n=110). Vortioxetine for eight weeks did not improve cognitive function; coenzyme Q10 500 mg/day for six weeks probably did not improve quality of life (n=119); SIM01 might alleviate fatigue (200 more per 1000 patients, 95% CI 94 more to 336 more; n=463) but probably did not improve quality of life. No instances of post-exertional malaise were reported in the rehabilitation trial; effects on serious adverse events were very uncertain.

  35. The effectiveness of exercise in alleviating long COVID symptoms: A systematic review and meta-analysis.2024 · systematic review
    Summary

    This systematic review and meta-analysis examined exercise interventions for long COVID symptoms. Nine studies involving 672 individuals were included; trials were based in eight countries, mainly in Europe and the Western Middle East. The included RCTs compared exercise with active or passive controls such as usual care, waitlist, exercise education, and sham respiratory devices. Exercise types included supervised combined aerobic and resistance exercise, aerobic exercise, multimodal exercise, breathing exercise, inspiratory muscle training, and Taichi, with printed durations such as 2-week, 5-week, 6-week, 8-week, 10-week, and 12-week. Outcomes were fatigue, dyspnea, anxiety, depression, and cognitive impairment. Exercise significantly improved long COVID fatigue (ES = 0.89, 95% CI: 0.27 to 1.50) and dyspnea (ES = 1.21, 95% CI [0.33, 2.09]), whereas no significant effect was identified on long COVID anxiety, depression, and cognitive impairment. Reported harms included symptom exacerbation in the sham group (One person/88) and dizziness (One minor/150); withdrawals included 57/148 and 21 dropouts. The authors state most included studies used subjective measurements and were at high risk of bias, and long-term effects remain unknown.

  36. Respiratory Muscle Strength Training in Patients Post-COVID-19: A Systematic Review.2024 · systematic review
    Summary

    This systematic review evaluated respiratory muscle strength training for individuals with post-COVID-19 dyspnea. The authors searched CINAHL, Web of Science, PubMed, EMBASE, Google Scholar, and Scopus for articles from 2020-2023; eleven articles met the inclusion criteria. The abstract does not report how many participants were included, the treatment duration, the comparison conditions, or the settings of the included studies. It states that pulmonary measures improved and that dyspnea, physical capacity and quality of life measures achieved statistical significance. The authors concluded: “Outcomes improved following respiratory muscle strength training as a standalone intervention, or with aerobic and peripheral muscle strength training.” Because this is a systematic review, that statement is the authors' conclusion across the included articles, not a finding of a new study. The abstract does not report side effects, withdrawals, or limitations. No individual study results, participant numbers, or harms are given in the abstract. The abstract also gives no details about the included study designs or participant characteristics.

  37. Effects of rehabilitation interventions for old adults with long COVID: A systematic review and meta-analysis of randomised controlled trials.2024 · systematic review
    Summary

    This systematic review and meta-analysis examined rehabilitation interventions for old adults with long COVID. It searched PubMed, EMBASE, Web of Science, Scopus, and Cochrane Library databases to 15 November 2023 and included 11 RCTs involving 832 participants (64.37 ± 7.94 years; 52.2% were men) with a mean/median age of 60 or older. Rehabilitation interventions included exercise training and respiratory rehabilitation; duration was not reported. They were compared with control groups (usual/standard care/placebo). Outcomes included 6 MWT, 30 seconds STS, HGS, FEV1/FVC, fatigue, quality of life, independence in activities of daily living, depression, and anxiety. Compared with controls, the review reported improvement in 6 MWT (MD = 15.77 m, 95% CI = 5.40, 26.13, P < 0.01), 30 seconds STS (MD = 4.11 n, 95% CI = 2.46, 5.76, P < 0.001), fatigue (SMD = −0.66, 95% CI = −1.13, −0.19, P < 0.01), independence in activities of daily living (SMD = 0.31, 95% CI = 0.13, 0.48, P < 0.001), depression (SMD = −0.89, 95% CI = −1.76, −0.02, P < 0.05), anxiety (SMD = −0.81, 95% CI = −1.58, −0.05, P < 0.05), and all SF-36 quality-of-life domains. HGS was not significant (MD = 1.67 kg, 95% CI = −0.84, 4.18, P > 0.05), and FEV1/FVC was not significant (MD = 3.45%, 95% CI = −1.43%, 8.33%, P > 0.05). Side effects and withdrawals were not reported.

  38. Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19 Condition: A Systematic Review and Meta-Analysis.2023 · systematic review
    Summary

    This systematic review with bayesian meta-analysis searched MEDLINE, Scopus, CINAHL, and the Clinical Trials Registry from January 2020 until February 2023 and included 14 trials (1244 patients; 45% female participants; median [IQR] age, 50 [47 to 56] years) with post–COVID-19 condition. It examined respiratory training and exercise-based rehabilitation interventions against placebo, usual care, waiting list, or control. The median follow-up for the primary outcome was 6 (5.5-7.0) weeks. For functional exercise capacity (6-minute walking test; 7 trials, 389 participants), the pooled SMD was −0.56 (95% CrI, −0.87 to −0.22). For lower limb muscle function (4 trials, 371 participants), the SMD was −0.77 (95% CrI, −1.94 to 0.44), with uncertain magnitude and direction. Dyspnea (8 trials, 573 participants) had SMD −1.00 (95% CrI, −1.94 to −0.10). FEV1 (6 trials, 363 participants) showed no difference: SMD −0.16 (95% CrI, −0.42 to 0.11); FVC showed no difference: SMD −0.13 (95% CrI, −0.38 to 0.12). Overall quality of life (5 trials, 366 participants) had SMD −0.41 (95% CrI, −0.73 to −0.06). Adverse events: OR 1.68 (95% CrI, 0.32 to 9.94); Five trials gave no adverse-event information, four trials (5 records) reported no related adverse events, and adverse events were reported in 5 trials. Fatigue evidence was limited and could not be synthesized. Worsening or stopping was not reported.

  39. Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation.2023 · systematic review
    Summary

    This systematic review asked what evidence exists on interventions for rehabilitation for COVID-19-related limitations of functioning in adults with COVID-19 or post COVID-19 condition (PCC). It included 53 RCTs with 3882 randomized participants; included adults were hospitalized or managed at home, and the review covered non-severe, severe, critical COVID-19 and PCC. Interventions were compared with usual care, sham/placebo, no treatment, or another active intervention; duration was not reported. Outcomes covered body functions, activities and participation, quality of life, and adverse events. The review synthesized evidence narratively. It reports that the effect of breathing and strengthening exercise programs on dyspnea and physical exercise capacity compared to no treatment in non-severe COVID-19 patients is uncertain. Multicomponent telerehabilitation may slightly increase physical exercise capacity compared to educational intervention in adults with PCC, but uncertainty remains about its effect on lung function and physical exercise capacity compared to no treatment; it reported no evidence of an effect on FVC and FEV1/FVC% for multicomponent telerehabilitation compared to no treatment in PCC. The effect of inspiratory muscle training on maximal inspiratory pressure compared to no treatment in adults with PCC is uncertain. For harms, four grouped studies and fourteen studies reported no adverse events; five and three mild adverse events (transient skin redness) occurred in active HD-tDCS and sham groups, respectively; one person in the sham group presented symptom exacerbation; olfactory training had two (0.8%) headache reports and one (0.4%) worsening parosmia report. The authors state they cannot provide robust suggestions for practice.

  40. What treatments work for anxiety and depression in children and adolescents with chronic fatigue syndrome? An updated systematic review.2022 · systematic review
    Summary

    This systematic review updated searches from 2015 to 2020 in Cochrane Library, Medline, Embase and PsycINFO for studies of children and adolescents with CFS/ME and validated measures of depression and/or anxiety. Combined with previous reviews, 16 studies and 965 participants were included; follow-up ranged from immediately post-treatment to 21 years. Treatments included CBT, the Lightning Process, valacyclovir, pacing, gammaglobulin, placebo, and inpatient or specialist care programmes. An RCT compared Lightning Process plus specialist medical care with specialist medical care alone; the review reports adjusted mean differences in depression and anxiety scores at 6 and 12 months, for example depression −1.5 (−3.5 to 0.5, 0.1) at 6 months and −1.8 (−3.4 to −0.1, 0.04) at 12 months. An observational cohort of routine specialist care measured depression and anxiety at baseline but not post-treatment. CBT-type interventions had most evidence for improving comorbid anxiety and/or depressive symptoms, but delivery and modality varied. A trial reported a deterioration in school attendance in the pacing arm. The review reports insufficient evidence to draw conclusions, and no study specifically targeted depression or anxiety. The authors state the evidence is poor and insufficient for meta-analysis.

  41. Treatment for paediatric chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME) and comorbid depression: a systematic review.2016 · systematic review
    Summary

    This systematic review asked which treatments for depression are effective in children and young people with CFS/ME, and whether comorbid depression affects outcome. MEDLINE, EMBASE, PsycInfo and the Cochrane library were searched in February 2015; 9 studies met the inclusion criteria. No study specifically tested a treatment for paediatric CFS/ME with depression, and no study stratified outcome by depression severity. Included studies examined CBT-based rehabilitation (up to 15 hourly sessions; n=23), telephone CBT guided self-help (6 fortnightly 30-minute sessions; n=63, 52 at follow-up), 4-week multicomponent inpatient programmes (n=39, 19 at follow-up; n=16; RCT n=22 comparing aerobic and resistance training), and valacyclovir (n=15, 14 at follow-up; treatment 3 to 60 months, mean 27.9 months). Depression and fatigue were measured. There was no overall comparison group; the included RCT compared aerobic with resistance training. Chalder et al reported depression significantly improved; Denborough et al reported mean BDI was 21 pretreatment and 15 post-treatment and improvement maintained at 6-month follow-up; Gordon and Lubitz reported significant improvement in BDI and Fatigue Severity scores; both RCT arms improved in BDI; Lloyd et al reported improvements in depression at 6 months; Henderson et al reported depression symptoms decreased in depressed and non-depressed patients and all patients reported at least 80% self-rated improvement. Kawatani et al found no significant improvement in fatigue at 6-month follow-up; mood was not reassessed. Reported concerns included that SSRIs can increase suicidality and that exercise could exacerbate symptoms in patients with CFS/ME; Denborough et al reported internalising problems escalated above preadmission levels.

  42. An abridged version of the Cochrane review of exercise therapy for chronic fatigue syndrome.2016 · systematic review
    Summary

    This systematic review asked whether exercise therapy affects adults with chronic fatigue syndrome (CFS). It included eight randomised clinical studies that reported data from 1518 participants over 18 years with a primary diagnosis of CFS, able to attend an outpatient clinic, from all health care settings. Exercise therapy was compared with 'passive' control, treatment as usual, and cognitive behaviour therapy, with outcomes at end of treatment. For fatigue, seven of eight studies (842 participant) gave a pooled SMD estimate of -0.68 units (95% Cl -1.02 to -0.35) favouring exercise therapy. Individual fatigue reductions were 6.06 points (95% Cl -6.95 to -5.17), 2.82 points (95% Cl -4.07 to -1.57), and 6.80 points (95% Cl -10.31 to -3.28). Exercise therapy versus control showed physical functioning MD 13.10 (95% Cl 1.98 to 24.22), sleep MD -1.49 (95% Cl -2.95 to -0.02), and self-perceived overall health RR 1.83 (95% Cl 1.39 to 2.40). Versus CBT, one trial (298 participants) reported little or no difference in fatigue: MD 0.20 (95% Cl -1.49 to 1.89). Serious adverse reactions were rare: RR 0.99 (95% Cl 0.14 to 6.97) with 2 of 160 versus 2 of 159, and versus CBT RR 0.67 (95% Cl 0.11 to 3.96). Stopping treatment was not reported. The authors state no evidence suggests exercise therapy may worsen outcomes. They state the evidence was too sparse and/or of too low quality for pain, quality of life, anxiety or depression, and that a wide confidence interval made firm conclusions impossible.

  43. Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities.2026 · review
    Summary

    This narrative review used pragmatic methods and searches up to January 2025 to map candidate treatments for long COVID that clinicians and people with lived experience prioritised. No participant total for the review itself was reported. Evidence was summarised across intervention groups. A moderate-quality RCT of 155 participants found no significant improvement with Paxlovid. In a non-randomised controlled trial of fexofenadine plus famotidine, 14 patients were in the treatment group and 13 in the control group; 29% of treated patients had complete resolution of long COVID symptoms, and all treated patients showed significant improvement in fatigue, brain fog, abdominal disorders, and increased heart rate compared with controls. A single case report found eight out of 12 reported improved cognitive abilities with guanfacine plus N-acetylcysteine; four patients discontinued therapy, two for unspecified reasons and two due to hypotension and/or dizziness. A pilot RCT of 13 participants found active taVNS (n = 8) improved fatigue, mood, and cognitive symptoms compared with sham (n = 5), with no serious adverse events observed. A small RCT found no significant differences with 700 mg leronlimab. Two RCTs did not report any benefit from CoQ10. A case study of 4 participants reported symptom improvements up to 6 months after nicotine patches 7.5 mg per day for 7 days. Five RCTs reported multicomponent interventions improved quality of life and dyspnoea, with no strong evidence for other symptoms; 16 RCTs examined exercise training.

  44. Assessment and management of post-COVID-19 pulmonary complications: a rapid review.2026 · review
    Summary

    This rapid review assessed evidence on management and treatment of pulmonary complications in post-COVID-19 condition (PCC). It included 73 unique records from published and grey literature; these comprised guidance documents, secondary studies and primary research studies. Included primary studies involved adults with PCC and pulmonary complications, with individual study sizes that included 28 and 871 participants. Interventions included IHHT plus standard rehabilitation, nirmatrelvir plus ritonavir, hyperbaric oxygen, systemic corticosteroids, and multicomponent exercise rehabilitation. Comparisons included standard rehabilitation, placebo plus ritonavir, sham treatment, nonsteroid care, and usual care or control. Outcomes included 6MWT distance, Borg and PROMIS dyspnoea, RAND-36 physical function, FEV1, FVC, FVC % pred, resting oxygen requirement and adverse events. Doehner 2024 reported a significant between-group difference in 6MWT distance favouring IHHT plus rehabilitation (p<0.001). Geng 2024 found no between-group difference in PROMIS dyspnoea (p>0.05). Kjellberg 2025 found no difference in RAND-36 physical function (p=0.277) or 6MWT distance (p=0.62) with hyperbaric oxygen versus sham. Ntiamoah 2024 reported significant improvements in FEV1, FVC and FVC % pred in the steroid group only. Torres 2024 reported FVC % pred improved from 52±0.17% to 60±0.20% (p=0.019) and resting oxygen requirement reduced (p=0.005), with no significant change in 6MWT distance (p=0.50). Seo 2025 reported diarrhoea in 80% of patients with nintedanib; Ora 2023 reported no adverse events with sodium pyruvate nasal spray. The authors state study quality and risk of bias were heterogeneous and findings should be interpreted with caution.

  45. Exercise and Cardiovascular Risk Modulation in Post-COVID Syndrome.2026 · review
    Summary

    This narrative review asked how exercise might modify cardiovascular risk in post-COVID syndrome (PASC). It searched PubMed/MEDLINE, Embase, Scopus and Web of Science for publications from January 2020 through March 2026; no overall number of included studies or participants was reported. The review summarized exercise studies in people with post-COVID syndrome or COVID-19 survivors. Interventions included aerobic, resistance, combined, respiratory, supervised endurance and concurrent training, compared with non-exercise, usual care, or unsupervised home-based groups. Durations included 8 weeks, a 12-week supervised program. Du et al. included 33 randomized controlled trials and 2,895 participants; Tartibian et al. included 296 COVID-19 survivors aged 20–93 years; Ferrari et al. analyzed 1,171 participants from eighteen RCTs; one prospective trial had 24 patients. Reported findings included improved functional capacity, dyspnea and quality of life; increased VO₂peak and reduced fatigue; improved functional capacity and muscle strength, with low to very low certainty; and reductions in CRP and pro-inflammatory chemokines. Effects on quality of life and cardiopulmonary efficiency outcomes were less consistent. The review stated the evidence does not yet demonstrate that exercise reverses accelerated vascular aging or reduces major adverse cardiovascular events. It reported no side-effect counts and stated post-exertional symptom exacerbation should be monitored for 24–48 h post-exercise. No counts of people who worsened or stopped were reported.

  46. Physiotherapy interventions in post- and long-COVID-19: a scoping review of the literature up to February 2023.2025 · review
    Summary

    This scoping review asked what physiotherapy interventions and treatment parameters have been published for post- and long-COVID-19. The authors searched PubMed, EBSCO, Scopus, Web of Science, Embase, PEDRO, Cochrane and WISO in March 2023 and included 6 studies; they state no published study focusing on long-COVID-19 was identified. The included studies covered respiratory therapy, aerobic training, strength training, and in a study ‘hands-on’ physiotherapy. Comparisons varied: some randomised trials compared training or breathing interventions between groups, while case reports described before-and-after courses. Reports included 60 patients (31 female, 29 male), 52 men, 65 men, 32 patients (20 female, 12 male), and case reports of a 37-year-old woman and a 60-year-old woman. Measured outcomes included fatigue, walking distance, dyspnoea, quality of life, muscle strength, lung function and adverse events. Reported changes included fatigue reduction, for example Nagy study group from 43.36 to 28.68 and control group from 42.47 to 39.77, and walking distance increases, for example Rutkowski VR group from 502 to 558 m and control group from 512 to 552 m. Muscle mass and lung function were reported as unchanged; one case report reported decreased quality of life. The authors state treatment descriptions were often inadequate and the data were summarised descriptively, limiting conclusions about effectiveness.

  47. Interventions for Long COVID: A Narrative Review.2025 · review
    Summary

    This narrative review synthesized evidence from 97 studies (n=8260, 103 publications) on interventions for common long COVID symptoms: fatigue, neurocognitive symptoms, anxiety, depression, and sleep issues. The review included randomized and non-randomized studies and compared medications, rehabilitation, behavioral and mind-body programs, supplements, complementary treatments, and COVID-19 vaccination with placebo, usual care, no treatment, or other active comparators. For vortioxetine versus placebo, one RCT (n = 141) reported a significant reduction in depression symptoms (adjMD of −1.52; 95% CI −2.85 to −0.19) and improvement in quality of life (WHO-5, adjMD of 2.36; 95% CI 0.77 to 3.94), with mixed cognitive results. An RCT of “Fit after COVID” CBT (n=114) reported improvement in fatigue (CIS-fatigue: MD −8.8; 95% CI −11.9 to −5.8), cognitive impairment (CIS-concentration: MD −5.1; 95% CI −6.9 to −3.4), and physical function (SF-36-Physical Health: MD 7.1; 95% CI 2.9 to 11.3). Hyperbaric oxygen therapy (n=73) improved fatigue (SF-36 energy subscale, 18.2 vs 6.0, p=0.029) and sleep quality (PSQI, 8.1 vs 9.2, p=0.042) versus sham. Transcranial direct current stimulation (n=47) reduced physical fatigue (MFIS-Physical: p=0.034) but not overall fatigue (MFIS-Total: p=0.184). A COVID-19 vaccine study (n=453) found no statistically significant difference in fatigue, depression, or sleep quality. Adverse events included treatment-related reactions with vortioxetine (26.8% vs. 22.1%), non-serious adverse events with AXA1125 (RR 2.62, 95% CI 1.00 to 6.89), and similar adverse event rates with SIM01 (10% vs. 11%; p=0.63).

  48. Long COVID management: a mini review of current recommendations and underutilized modalities.2024 · review
    Summary

    This mini review addresses long COVID, described as symptoms developing in a subset of patients after COVID-19 infection across multiple organ systems. The authors state it aims to give primary care providers highlights from existing literature on common long COVID symptoms and management recommendations, and to highlight underutilized interventions: stellate ganglion block (SGB) and low-dose naltrexone (LDN). It is a review, not a new study; no enrolled or analysed patient number is reported for the review itself. For SGB, the text cites a retrospective cohort study of 41 participants with long COVID symptoms: reduction of at least one symptom was reported in 86%, relief of all presenting initial symptoms in 61%, most reported improvement within 15-min, other improvement over 1–2 weeks, and at 9-to-12-month follow-up only 2 patients reported return of symptoms. In a parosmia study comparing interventions, SGB had the lowest utilization but the highest reported percentage improvement among participants with maintained benefit. The review lists SGB adverse events including hoarseness, lightheadedness, cough, dyspnea, migraine headaches, ptosis, hematoma formation, dural puncture, local infection (two cases with patients on steroids), and risk of pneumothorax or injury of adjacent structures. It states LDN is associated with minimal side effects. The authors conclude that, in addition to multidisciplinary rehabilitation, early referral to interventional pain management for consideration of SGB or initiation of LDN to alleviate long COVID symptoms. They state that many recommendations are based on expert opinion and that more research is urgently needed.

  49. Treatable traits for long COVID.2023 · review
    Summary

    This comprehensive review asked how a treatable traits approach could be applied to long COVID. It combined an umbrella review of 22 systematic reviews identifying long COVID symptoms and complications with a systematic review of 18 randomized controlled trials of prevention or management. The trials tested many interventions, including metformin for 14 days during acute COVID-19 versus placebo, hyperbaric oxygen therapy versus sham, exercise training or respiratory muscle training versus usual care or sham, HD-tDCS versus sham, L-arginine plus liposomal vitamin C versus placebo, aromatherapy versus inert oils, and platelet-rich plasma injections versus saline. Outcomes included long COVID incidence, cognition, olfaction, dyspnoea, fatigue, exercise capacity and health-related quality of life. In one prevention trial, metformin was associated with reduced long COVID incidence at 10 months (hazard ratio 0.58 [95% CI 0.38, 0.88]) among 564 metformin and 561 placebo participants; ivermectin and fluvoxamine showed no significant benefit. For management, hyperbaric oxygen improved cognition compared with sham (104.1 ± 7.2 versus 101.3 ± 8.9, p = 0.038), and exercise training improved exercise capacity compared with exercise advice (38.9 ± 10.8 versus 36.1 ± 9.5 mL/kg/min, p = 0.035). Some studies found no significant between-group differences, including a larger exercise trial. Adverse events included 13 during hyperbaric oxygen versus 14 during control; one aromatherapy participant withdrew on day 13 with headaches, and one sham IMT participant withdrew for symptom exacerbation. The authors state the review was limited by not conducting a meta-analysis and by heterogeneity of the included systematic reviews.

  50. Long Covid — Pathophysiology and Treatment2021 · review
    Summary

    This review examined long COVID pathophysiology and treatment. It did not conduct a primary study, so the number enrolled and analysed in this paper is not reported; the setting is not reported. The review discusses rehabilitation and other interventions. It reports a study by Daynes of 30 patients with long COVID given a six weeks rehabilitation programme with two supervised sessions per week; patients' aerobic capacity improved and no serious adverse events were recorded. It also cites a study [35] of CFS patients undergoing a physical activity programme based on aerobic physical activity, in which a Fifty one percent dropout rate was noted due to post-exertional malaise (PEM). A yet not peer-reviewed small study [37] suggested that AstraZeneca and Pfizer-BioNTech vaccines were related with overall improvements in symptoms in long COVID patients. The review states there is no proven treatment for long COVID. It notes no clear data on the natural course of COVID 19 and pathophysiology mechanism leading to long COVID. It also states that physical exercise programme in ME/CFS might be deleterious to some patients.

  51. Benefits of physical training in fibromyalgia and related syndromes.2007 · review
    Summary

    This literature review asked whether physical training benefits fibromyalgia (FM) and related syndromes, including chronic fatigue syndrome (CFS). The authors searched Medline (Ovid and PubMed) for articles on FM, CFS, therapy, rehabilitation, aerobic exercise, exercise, and cognitive behavioral therapy; no review-level number of patients or included studies was reported. The review summarizes trials of graded exercise/physical training and other treatments. A CFS study allocated 66 patients to a daily aerobic exercise program or to relaxation plus flexibility exercises; well-being improved in 55% versus 27%, and the authors reported benefits for fatigue and physical function. In FM studies, aerobic exercise was compared with flexibility sessions, with improvements in physical function and pain threshold but no difference in pain intensity or sleep disturbances. Other summarized programs reported improvements in pain, endurance, tender point count, fitness, function, mood, and fatigue, while some outcomes did not improve. A pregabalin trial (450 mg/day versus placebo) reported pain, fatigue, and sleep improvements. The review also reports adverse effects from antidepressant medications and a tolerable short-term increase in pain and fatigue during early exercise sessions.

  52. Chronic fatigue syndrome: matching exercise to symptom fluctuations.2004 · review
    Summary

    This paper is a review of exercise for chronic fatigue syndrome (CFS), not a primary study; it reports no own enrolled or analysed participant numbers. It discusses Whiting et al23, a systematic review that included 44 studies and 2,801 patients with CFS, in which cognitive behavioral therapy (CBT) and graded exercise therapy showed promising results. An exercise training study22 in CFS patients lasting 4 to 6 months reported that the ability to perform aerobic exercise increased 13%; patients had less fatigue, a lower HR, a lower RPE, increased functional capacity, and fewer symptoms. In a large-scale study25, 1,092 veterans with Gulf War veterans' illnesses (GWVI) were randomly assigned to one of four treatment arms; neither aerobic exercise nor CBT had a significant impact on physical function, but both treatments, especially exercise, resulted in less fatigue, fewer cognitive symptoms, less distress, and improved mental health functioning. Clapp et al8 found no changes immediately after 30 minutes of light, intermittent exercise (three 10-minute bouts) or 1 week later; all10 patients believed they could not walk for 30 minutes without exacerbating symptoms. Reported harms include that exercise can provoke anxiety and a feeling of increased vulnerability to pain and fatigue, fatigue may be greater for the first few days, and a rapid introduction of overly strenuous exercise is likely to exacerbate symptoms. The authors state that CFS is difficult to study because patients are heterogeneous and symptoms fluctuate.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime